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Introduction
In heart failure with preserved ejection fraction (HFpEF), the 
spectrum of diastolic abnormalities is wide and easily identified 
on transthoracic echocardiography (TTE) at rest.1) HFpEF is also 
accompanied by a variety of clinical manifestations that are 
associated with the level of left ventricular end-diastolic pressure 
(LVEDP). In patients who present with overt heart failure (HF), LVEDP 
is increased at rest, which can be diagnosed by means of resting 
TTE. Unfortunately, most patients with HFpEF who present at an 
outpatient clinic complain of only exertional symptoms in the absence 
of apparent volume overload — the so-called milder or “early” phase 
of HFpEF.2-5) In early HFpEF, resting left ventricular (LV) filling pressure 
is within the normal range, as determined by catheterization (LVEDP 
and pulmonary capillary wedge pressure [PCWP]), by TTE (the e/e´ 
ratio), or by the level of brain natriuretic peptide (BNP); hemodynamic 
derangements develop only during the stress of exercise.2) As a result, 
euvolemic patients with early HFpEF will not meet current diagnostic 
criteria and algorithms based on resting hemodynamics alone.2) 
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According to recent studies, based on current diagnostic guidelines 
issued by the European Society of Cardiology (ESC), HFpEF was 
diagnosed in 25% to 34% of patients with early HFpEF and in 24% 
with non-cardiac dyspnea.2)5) Furthermore, the hitherto commonly 
used radiographic, laboratory, and echocardiographic variables are 
also useless, so diagnosing HFpEF presents a challenge. Invasive 
hemodynamic assessment can help resolve this dilemma, in that a 
PCWP>12 mmHg or an LVEDP>16 mmHg will confirm the diagnosis.3-6) 
Recently, the results of invasively measured PCWP were correlated 
with long-term prognosis.4) However, because resting LVEDP as 
determined invasively falls within the normal range in early HFpEF, a 
diagnosis based solely on the result of this test may miss patients with 
early HFpEF.2-5) Whether or not a diagnosis based on surrogate markers 
of elevated LVEDP is valid is a matter of controversy. However, recent 
studies have shown that the diagnosis of early HFpEF can be made 
only by assessing hemodynamic responses during exercise and that 
invasive tests to determine exercise hemodynamics are needed for this 
diagnosis to be made with greater accuracy.2) Thus, researchers have 
recently begun to take into account the necessity and significance of 
the invasive hemodynamic stress test to investigate the mechanisms, 
diagnosis, and prognosis of this disorder.2-5)
In addition, invasive testing of exercise hemodynamics allows a 
more objective assessment of the effect of stress or exercise on 
diastolic function in early HFpEF — so-called diastolic functional 
reserve (DFR).2)7)8) It has been proven that DFR is also reduced in 
patients with HFpEF who have impaired diastolic function.7-9) The 
gold standard for measuring DFR is diastolic stress echocardiography 
(DSE), and a modified method is known as the passive leg-raise 
(PLR) test using TTE.1)10-12) Although the diagnosis of HFpEF requires 
objective evidence of elevated LV filling pressure, there has hitherto 
been no way to assess DFR invasively and simultaneously in patients 
with HFpEF who are undergoing coronary angiography (CAG) or 
left cardiac catheterization. Thus, the DFR or PLR test should be 
carried out at another time or place. Moreover, little is known about 
invasively measured DFR and therefore about serial changes in 
LV pressure in response to leg-raise exercise, a marker of DFR, in 
patients with early HFpEF found to have normal levels of BNP.
Thus, the aims of this study were (1) to investigate invasively 
the serial changes in LVEDP in response to leg-raise exercise in 
euvolemic patients with early HF and (2) to evaluate the relationship 
between serial changes in invasively measured LVEDP during leg-
raise and echocardiographic results or clinical characteristics.
Subjects and Methods
Study population
This prospective, single-center (Hanyang University Guri Hospital, 
Guri, Korea) cohort study was conducted between July 2013 and 
April 2015. It included 181 consecutive patients with normal LV 
ejection fraction (EF) (>50%) and exertional dyspnea of at least 3 
months’ duration who were found to have early HFpEF on invasive 
hemodynamic assessment. Because early HFpEF can be considered 
objective evidence of LV diastolic dysfunction in euvolemic patients 
with dyspnea that occurs only during exercise, we screened 
outpatients who presented with New York Heart Association 
(NYHA) class II or III exertional dyspnea or equivalent symptoms 
(chest discomfort). Also, the patients’ history also had to include 
at least one of the following: edema, improvement of symptoms 
with diuretic therapy, or cardiomegaly. TTE and BNP assay were 
performed on the day of admission. To document LV hemodynamics 
on invasive testing in early HFpEF, the BNP level should be within 
the normal range; therefore, patients with BNP>200 pg/mL were 
excluded owing to evidence of apparent HF.
Because there is no model for predicting normal hemodynamics 
at rest and abnormal hemodynamics on exercise, we used the 
echocardiographic criterion of LV diastolic dysfunction to screen 
the study population. Based on findings that normal LV systolic and 
diastolic function are usually defined as EF>50%, an E/A ratio>1, 
and e´ velocity>8 cm/s, we selected patients with EF>50% and 
e <´8 cm/s or an E/A ratio<1 to isolate those patients with objective 
evidence of LV diastolic dysfunction. Moreover, since septal e/e´ 
ratios of either <8 or >15 are considered to indicate either normal 
or increased LV filling pressure, respectively, we added 8<septal 
e/e´ ratio<15 as another inclusion criterion.
The diagnostic criteria and algorithm for early HFpEF were 
explained to patients who were scheduled to undergo CAG to 
assess their exertional symptoms. Informed consent was obtained 
from each patient prior to left cardiac catheterization and the leg-
raise test. Initially, we recruited 350 patients who had EF>50% and 
8<septal e/e´ ratio<15, an E/A ratio<1, or an e´ value<8 cm/s based 
on resting TTE. Eight patients withdrew consent before undergoing 
CAG; thus, CAG was performed in 342 patients. Because 112 
patients were found to have coronary artery stenosis>50% on CAG, 
the remaining 230 patients underwent left cardiac catheterization 
with leg-raise exercise. Twenty patients were unable to successfully 
complete the active leg-raise (ALR) exercise for 3 minutes, and 3 
patients had LVEDP<16 mmHg. TTE using leg-raise was performed 
within 24 hours to compare the invasively measured LVEDP with 
the e/e´ ratio, and 26 more patients were excluded from the 
study cohort. Eventually, 181 patients with exertional dyspnea or 
equivalent symptoms were included in the final analysis.
To enhance the homogeneity of the study population, patients 
were excluded if they had a history of coronary revascularization, 
previous cardiac surgery, myocardial infarction, end-stage renal 
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disease, chronic liver disease, or cancer or if they had evidence of 
chronic obstructive pulmonary disease, frequent atrial or ventricular 
arrhythmias (ectopic focus>6 beats/minutes or atrial fibrillation), or 
chronic kidney disease. Also, patients with moderate to severe valve 
disease, cardiomyopathy, pericardial disease, intracardiac shunt, 
pulmonary arterial hypertension, or reduced EF (EF<50%) on TTE 
were excluded, as were patients who had a poor echo window or in 
whom measurement of LVEDP proved problematic. This study was 
approved by the Ethics Committee of the institutional review board 
at Hanyang University Guri Hospital.
Definition of hypertension, diabetes, and dyslipidemia 
Hypertension was diagnosed if the office blood pressure (BP) 
measurement was ≥140/≥90 mmHg or if the patient was on chronic 
antihypertensive medication. On the basis of American Diabetes 
Association criteria, diabetes mellitus (DM) was defined as a fasting 
plasma glucose≥126 mg/dL, a glycated hemoglobin≥6.5% or on anti-
diabetic medication.13) According to the 2004 update of the National 
Cholesterol Education Program guidelines, dyslipidemia was present 
if low-density lipoprotein cholesterol was ≥160 mg/dL, high-density 
lipoprotein cholesterol was ≤40 mg/dL, triglycerides were ≥150 mg/dL, 
or the subject was on chronic lipid-lowering medication.14) Subjects 
Table 1. Abbreviations and definitions of hemodynamic parameters*
Abbreviation Definition
BP (mmHg) Blood pressure
LVSBP (mmHg) Left ventricular systolic BP
LVDBP (mmHg) Left ventricular diastolic BP
Aortic SBP (mmHg) Aortic systolic BP 
Aortic DBP (mmHg) Aortic diastolic BP
LVSBP minimum (mmHg) Lowest value in LVSBP
LVSBP maximum (mmHg) Highest value in LVSBP
LVSBPs minimum (mmHg) Lowest value in LVSBP at the end of active leg-raise
LVSBPs maximum (mmHg) Highest value in LVSBP at the end of active leg-raise
LVDBP minimum (mmHg) Lowest value in LVDBP
LVDBP maximum (mmHg) Highest value in LVDBP
LVDBPs minimum (mmHg) Lowest value in LVDBP at the end of active leg-raise
LVDBPs maximum (mmHg) Highest value in LVDBP at the end of active leg-raise
LVEDP (mmHg) Left ventricular end-diastolic pressure
LVEDP minimum (mmHg) Lowest value in LVEDP
LVEDP maximum (mmHg) Highest value in LVEDP
LVEDP frequent (mmHg) Most common value in LVEDP
LVEDPs minimum (mmHg) Lowest value in LVEDP at the end of active leg-raise
LVEDPs maximum (mmHg) Highest value in LVEDP at the end of active leg-raise
LVEDPs frequent (mmHg) Most common value in LVEDP at the end of active leg-raise
Pre-aLVDP minimum (mmHg) Lowest value in pre-aLVDP
Pre-aLVDP maximum (mmHg) Highest value in pre-aLVDP
Pre-aLVDP frequent (mmHg) Most common value in pre-aLVDP
Pre-aLVDPs minimum (mmHg) Lowest value in pre-aLVDP at the end of active leg-raise
Pre-aLVDPs maximum (mmHg) Highest value in pre-aLVDP at the end of active leg-raise
Pre-aLVDPs frequent (mmHg) Most common value in pre-aLVDP at the end of active leg-raise
∆LVEDP frequent (mmHg) Difference of LVEDP_frequent between rest and leg-raise
HR (beats/minute) Heart rate at initial stage
HRs (beats/minute) Heart rate at the end of active leg-raise
∆HRs (beats/minute) Difference in heart rate between rest and leg-raise 
* note that “s” denotes end of active leg-raise and “pre-a” denotes onset of the a-wave
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EKG
Pre-aLVDP Pre-aLVDP Pre-aLVDP
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LVEDP LVEDP LVEDP
LVDBP
LV dP/dt LV dP/dt LV dP/dt
Heart rate Heart rate
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LV pressure
QRS
P
QRS
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QRS
Fig. 1. Measurement of LVEDP and pre-aLVDP. The pre-aLVDP is measured at the onset of the a-wave, and the measurement of LVEDP is made at the 
nadir of the atrial contraction wave before the onset of a rapid rise in left ventricular (LV) systolic pressure or at the peak of R-wave on EKG. LVEDP: left 
ventricular end-diastolic pressure, pre-aLVDP: pre-a left ventricular diastolic pressure, LV: left ventricle, EKG: electrocardiography, P: P wave, QRS: QRS 
complex, LVSBP: left ventricle systolic blood pressure, LVDBP: left ventricle diastolic blood pressure.
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Fig. 2. Association of the invasively measured LVEDPs between the echocardiographic e/e´ ratios during leg-raise. Leg-raise, especially active leg-raise, 
significantly increases all types of LVEDP parameters. Unlike the invasively measured LVEDP, the septal e/e´ ratio is not significantly changed during passive 
and active leg-raise. “p” indicates passive leg-raise, “a” active leg-raise, and “R” recovery period. For example, p30 is at 30-second passive leg-raise. ∗p<0.05 
vs. baseline at passive stage, †p<0.01 vs. at a0. LVEDP: left ventricular end-diastolic pressure.
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Fig. 3. Time course of the invasively measured LVEDP according to the LVEDP response to leg-raise. In most of the patients (77.9%), LVEDP increased 
steadily throughout active leg-raise. In contrast, LVEDP in 22.1% of the patients increased moderately during the early stage of active leg-raise and then 
declined during the late stage, relative to the initial stage. “p” indicates passive leg-raise, “a” active leg-raise, and “R” recovery period. For example, p30 is at 
30-second passive leg-raise. ∗p<0.05 vs. baseline at passive stage, †p<0.01 vs. at a0, ‡p<0.01 vs. △LVEDP_frequent>0 mmHg. LVEDP: left ventricular end-
diastolic pressure.
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Fig. 4. Time course of septal e/e´ ratio according to the LVEDP response to leg-raise. Septal e/e´ ratios in the △LVEDP_frequent≤0 mmHg group were 
significantly lower at initial, passive, and active stages, as compared with those in the △LVEDP_frequent>0 mmHg group. However, septal e/e´ ratio 
showed no significant change during active leg-raise. “p” indicates passive leg-raise, “a” active leg-raise, and “R” recovery period. For example, p30 is at 
30-second passive leg-raise. ∗p<0.05 vs. baseline at passive stage. †p<0.01 vs. at a0, ‡p<0.05 vs. LVEDP of △LVEDP_frequent>0 mmHg, §p<0.05 vs. e/e´ 
ratio of △LVEDP_frequent>0 mmHg. LVEDP: left ventricular end-diastolic pressure.
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who had smoked at least 400 cigarettes during their lifetime were 
classified as ex-smokers or as current smokers on the basis of current 
smoking status. Subjects who had had at least one drink during their 
lifetime were categorized as ex-drinkers or as current drinkers on the 
basis of current alcohol intake.
Study protocol
Cardiac catheterization and exercise protocol
Standard CAG and left cardiac catheterization was performed 
through a 4-6 F sheath placed in the radial or femoral artery. 
A 4-F pigtail catheter was introduced into the LV to assess LV 
hemodynamics. Baseline pre-aLV diastolic pressure (pre-aLVDP) 
and LVEDP at rest were measured during steady states.
Leg-raise protocol
After resting hemodynamics has been assessed, the leg-raise 
exercise was performed in the supine position in two stages during LV 
catheterization with hemodynamic monitoring: PLR, during which the 
leg was passively placed on a 30-cm-high pillow for 3 minutes, and 
then (1 minute after PLR) ALR, during which the patient independently 
maintained the raised leg at a height of 20 cm for 3 minutes.
Transthoracic echocardiography image acquisition and analysis
Resting transthoracic echocardiography
Before CAG and cardiac catheterization, a standard TTE exam 
was performed with the use of a Philips iE33 ultrasound system 
with S5-1 transducer (Philips Medical Systems, Andover, MA, 
USA). LV end-diastolic volume, LV end-systolic volume, and EF 
were assessed using the modified biplane Simpson’s method. Left 
atrial volume was measured by means of the biapical area-length 
method. Transmitral velocities were measured on the apical four-
chamber view. Peak velocity for early filling (E), atrial contraction 
(A), and deceleration time for the E wave were also measured. 
Tissue Doppler imaging was performed, and peak systolic (s´ ), early 
(e´), and late (a´) velocities were measured for each annular side.
Serial e/e´  ratio measurement during leg-raise test
Baseline measurements were obtained with the patient in 
the supine position after equilibration with the feet elevated on 
the 30-cm-high pillow. Transmitral E wave and tissue Doppler 
septal annular velocity (e´) were measured. After baseline images 
had been obtained, PLR was performed. At 1-minute intervals, 
echocardiographic measurements were repeated during the leg-
raises. PLR and ALR were each maintained for 3 minutes.
Definition of heart failure with preserved ejection fraction on 
invasive left ventricular end-diastolic pressure measurement
On left cardiac catheterization, HFpEF or an elevated LVEDP was 
defined by LVEDP>16 mmHg at rest or during the leg-raise exercise, 
as described elsewhere.3-6) 
Table 2. Effect of leg-raise exercise on LV hemodynamic parameters
LV hemodynamic parameter
 Passive leg-raise Active leg-raise
0 second 180-second 0 second 180-second
LVSBP minimum (mmHg) 131.82±16.90 135.34±16.93 135.30±16.95 157.87±18.56*†
LVSBP maximum (mmHg) 136.72±17.16 139.63±17.5 140.24±16.82 165.17±19.09*†
LVDBP minimum (mmHg) −2.85±8.37 −1.66±8.84* −1.42±8.98* −0.58±10.37*†
LVDBP maximum (mmHg) 0.56±7.93 2.41±8.84* 1.90±8.53* 4.39±10.51*†
Heart rate (beats/minute) 73.65±10.28 72.45±9.58 72.70±10.61 84.23±17.28*†
LV dP/dt (mmHg/s) 2095.07±646.92 2011.11±616.16 2000.65±595.16 2398.57±725.37*†
LVEDP minimum (mmHg) 15.09±5.29 16.41±5.07* 17.14±4.57* 20.58±7.47*†
LVEDP maximum (mmHg) 19.57±5.74 20.91±5.48* 21.95±5.23* 28.56±8.29*†
LVEDP frequent (mmHg) 17.99±5.49 19.39±5.85* 19.65±5.01* 24.89±8.33*†
Pre-aLVDP minimum (mmHg) 6.93±3.46 8.34±3.68* 8.13±4.99* 8.26±8.63*
Pre-aLVDP maximum (mmHg) 10.85±3.13 12.17±3.39* 12.12±3.69* 14.15±8.24*†
Pre-aLVDP frequent (mmHg) 9.05±3.14 10.24±3.86* 10.09±4.53* 11.24±8.68*†
Active leg-raise leads to a significant increase in the value of LV hemodynamic parameters, whereas passive leg raise results in no significant change. 
∗p<0.05 vs. baseline at passive leg-raise, †p<0.05 vs. initial point at active leg-raise. LV: left ventricular, LVSBP: left ventricular systolic blood pressure, 
LVDBP: left ventricular diastolic blood pressure, LVEDP: left ventricular end-diastolic pressure, pre-aLVDP: pre-a left ventricular diastolic pressure
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Measurement of left ventricular hemodynamic parameters
LV hemodynamic function was assessed using heart rate (HR), 
LV systolic BP (LVSBP), LV diastolic BP (LVDBP), LVEDP, and rate 
of LV pressure change (dP/dt). As shown in Fig. 1, the pre-aLVDP 
was measured at the onset of the a-wave, and the measurement 
of LVEDP was made at the nadir of the atrial contraction wave 
before the onset of the rapid rise in LV systolic pressure by 
automatic mechanical measurement, as described elsewhere.15) 
The invasively measured LVEDP and pre-aLVDP were determined at 
baseline, at 30-second intervals during the leg-raise test, and until 
3 minutes after recovery. Because intrathoracic pressure swings 
are enhanced by the increased work of breathing during ALR, 
the individual LV hemodynamic parameters were separated into 
minimum, maximum, and frequent to adjust for the variability. Of 
10 consecutive LVEDPs of good quality, the lowest value of LVEDP 
was defined as LVEDP minimum and the highest value as LVEDP 
maximum. Among the remaining eight LVEDP values, the most 
frequent value was defined as LVEDP frequent. Like LVEDP, other 
Table 3. Comparison of LV hemodynamic parameters according to the LVEDP response to leg-raise exercise
LV hemodynamic parameter ∆LVEDP 0 mmHg(n=40)
∆LVEDP>0 mmHg
(n=141) p
∆LVEDP frequent during leg-raise (mmHg) −2.90±4.07 9.68±5.75 0.00 
∆LVEDP frequent during active leg-raise (mmHg) −4.10±3.21 7.89±5.24 0.00 
∆LVEDP frequent during passive leg-raise (mmHg) 1.00±2.28 1.50±2.36 0.52 
∆LVEDP frequent between two leg-raise (mmHg) 0.20±0.71 0.29±0.88 0.56
dP/dt at initial stage (mmHg/s) 2362.30±644.08 2019.26±466.85 0.01
dP/dt at active leg-raise (mmHg/s) 2695.00±549.65 2314.47±700.54 0.04 
∆dP/dt during leg-raise (mmHg/s) 252.60±115.61 250.68±109.20 0.14 
HR at initial stage (beats/minute) 78.90±10.75 72.16±9.73 0.10 
HR at active leg-raise (beats/minute) 89.90±27.75 82.63±12.23 0.07 
∆HR during leg-raise (beats/minute) 10.97±9.22 9.87±7.28 0.38 
LVEDP minimum (mmHg) 14.30±5.27 15.32±5.93 0.65 
LVEDP maximum (mmHg) 18.80±6.86 19.79±5.85 0.69 
LVEDP frequent (mmHg) 17.20±5.94 18.21±5.94 0.67 
LVEDPs minimum (mmHg) 12.80±4.08 22.79±7.10 0.00 
LVEDPs maximum (mmHg) 20.90±3.41 30.74±8.75 0.00 
LVEDPs frequent (mmHg) 14.30±4.08 27.89±6.94 0.00 
pre-aLVDP minimum (mmHg) 6.70±2.75 7.00±3.62 0.82 
pre-aLVDP maximum (mmHg) 10.9±1.60 10.84±3.69 0.96 
pre-aLVDP frequent (mmHg) 9.40±1.84 8.95±3.61 0.72 
pre-aLVDPs minimum (mmHg) 6.00±5.52 9.00±10.16 0.00 
pre-aLVDPs maximum (mmHg) 10.60±4.86 15.16±9.62 0.00 
pre-aLVDPs frequent (mmHg) 9.10±5.11 11.84±10.54 0.00 
LVSBP minimum (mmHg) 129.70±13.56 132.42±19.10 0.69 
LVSBP maximum (mmHg) 133.70±14.02 137.58±18.90 0.57 
LVSBPs minimum (mmHg) 147.20±14.82 160.89±19.35 0.06 
LVSBPs maximum (mmHg) 153.70±16.66 168.42±18.54 0.05 
LVDBP minimum (mmHg) −2.70±7.50 −2.89±9.62 0.96 
LVDBP maximum (mmHg) 1.40±5.85 0.32±9.54 0.75 
LVDBPs minimum (mmHg) −5.20±8.32 0.74±11.50 0.16 
LVDBPs maximum (mmHg) 0.00±8.19 5.63±11.82 0.19 
∆: difference, LV: left ventricular, LVEDP: left ventricular end-diastolic pressure, HR: heart rate, pre-aLVDP: pre-a left ventricular diastolic pressure, LVSBP: 
left ventricular systolic blood pressure, LVDBP: left ventricular diastolic blood pressure
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LV hemodynamic parameters were defined using the same system 
and format. Table 1 presents the abbreviations and definitions of 
each of the hemodynamic parameters assessed.
Intraobserver and interobserver variability
LV hemodynamic parameters were independently measured 
by two investigators. At first, to adjust for intraobserver and 
interobserver variability in the LVEDP parameters and e/e´ ratios 
reported, measurements of reliability and agreement were 
performed in a subsample of 30 patients. The intraclass correlation 
coefficient (ICC) for intraobserver variability for the three types of 
LVEDP (minimum, maximum, and frequent) were 0.94, 0.94, and 
0.96, respectively, at rest and 0.91, 0.94, and 0.94, respectively, 
during the leg-raise test. Similarly, the ICC for interobserver 
variability ranged from 0.92 to 0.94 at rest and from 0.91 to 
0.93 during leg-raise. As with the LVEDP parameters, the ICC for 
Table 4. Comparison of clinical characteristics according to the LVEDP response to leg-raise exercise
Clinical parameter ∆LVEDP 0 mmHg(n=40)
∆LVEDP>0 mmHg
(n=141) p
Age (years) 52.96±11.54 59.45±12.20 <0.01 
Sex (male) 21 (52.50) 66 (46.81) 0.59 
Hypertension 18 (45.00) 70 (49.64) 0.16 
RAA inhibitor 13 (32.50) 55 (39.01) 0.10
Beta blocker 8 (20.00) 25 (17.73) 0.23
Calcium-channel blocker 7 (17.50) 32 (22.70) 0.34
Diuretic 26 (65.00) 100 (70.92) 0.05
Diabetes mellitus 9 (22.50) 27 (19.15) 0.33 
Current smoker 13 (32.50) 42 (29.79) 0.79 
Current alcohol drinker 20 (50.00) 58 (41.13) 0.32 
Dyslipidemia 14 (35.00) 36 (25.53) 0.33
Dyspnea; NYHA class III 22 (55.00) 90 (63.83) 0.12
Edema 12 (32.50) 48 (34.04) 0.21 
Cardiomegaly 23 (57.50) 92 (65.25) 0.09
Body mass index (kg/m2) 24.31±4.95 25.25±4.99 0.10 
Abdominal circumference (cm) 86.33±8.31 89.09±9.50 0.11 
hs-CRP (mg/dL) 0.18±0.32 0.32±0.80 0.28 
BNP (pg/mL) 33.21±38.55 52.74±88.29 0.19 
D-dimer (ng/mL) 98.44±131.44 123.81±151.48 0.34 
Hemoglobin (g/dL) 13.59±1.61 13.24±1.50 0.20 
eGFR (mL/minute) 100.28±17.07 95.48±19.43 0.16 
Free T4 (ng/dL) 1.17±0.13 1.24±0.32 0.21 
Hemoglobin A1C (%) 6.05±1.63 5.75±0.90 0.14 
Glycoalbumin (%) 15.73±2.82 14.34±2.19 0.34 
Total cholesterol (mg/dL) 176.88±36.45 170.35±42.59 0.38 
Triglyceride (mg/dL) 145.78±62.12 142.59±72.6 0.80 
High-density lipoprotein (mg/dL) 47.63±8.34 50.16±12.9 0.10 
Low-density lipoprotein (mg/dL) 102.75±32.58 96.76±32.54 0.31 
Systolic BP (mmHg) 132.55±22.49 136.54±24.87 0.48
Diastolic BP (mmHg) 76.51±19.01 74.15±17.36 0.18 
Heart rate (beats/minute) 75.14±13.62 73.95±11.92 0.49 
Data are expressed as number (%) or mean±standard deviation. LVEDP: left ventricular end-diastolic pressure, RAA: renin-angiotensin-aldosterone, NYHA: 
New York Heart Association, hs-CRP: high sensitivity C-reactive protein, BNP: brain natriuretic peptide, eGFR: estimated glomerular filtration rate, BP: 
blood pressure 
358 Left Ventricular Hemodynamics in Euvolemic Patients with Exertional Dyspnea 
http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org
intraobserver and interobserver variability for the e/e´ ratio ranged 
from 0.81 to 0.90, which was relatively excellent. Next, a correlation 
analysis of LVEDP was carried out to determine the representative 
value among the three types of LVEDP parameters. Because the 
highest values of the correlation coefficients were associated with 
LVEDP frequent, this parameter was considered the representative 
value of LVEDP in the subsequent analysis.
Statistical analysis
Continuous variables are expressed as means±standard deviation, 
and categorical variables are expressed as percentages or 
frequency. Between-group comparisons of clinical characteristics, 
echocardiographic results, and LV hemodynamic data at rest and 
during leg-raise according to the change in LVEDP during leg-
raise exercise were performed using the independent samples 
t-test for continuous variables and the χ2 test or Fisher’s exact 
test for categorical variables. Within-group comparisons of LV 
hemodynamic parameters during leg-raise were performed using 
a repeated measures analysis of variance (ANOVA). When the 
difference was significant, intergroup comparisons were performed 
using Tukey’s multiple comparison test. LV hemodynamic and 
echocardiographic variables obtained at rest or during leg raise 
were compared with the paired sample t-test or repeated measures 
ANOVA.
Multivariate logistic regression analysis was performed to 
identify independent predictors for the LVEDP response during ALR. 
Table 5. Comparison of echocardiographic parameters according to the LVEDP response to leg-raise exercise
Echocardiographic parameter ∆LVEDP 0 mmHg(n=40)
∆LVEDP>0 mmHg
(n=141) p
Aorta diameter (mm) 32.80±4.46 31.90±4.47 0.21 
LA size (mm) 35.64±5.80 36.08±5.41 0.61 
LA length (mm) 42.50±16.81 42.54±17.72 0.99 
LA volume (mm³) 44.72±18.10 43.24±17.45 0.61 
LV end-diastolic diameter (mm) 50.00±5.32 48.79±5.45 0.16 
LV end-systolic diameter (mm) 32.71±4.63 31.39±4.38 0.06 
LV mass (mm³) 170.48±42.79 175.46±49.36 0.51 
LV relative wall thickness 0.27±0.09 0.29±0.07 0.14 
LV end-diastolic volume (mm³) 119.98±30.00 113.65±29.95 0.18 
LV end-systolic volume (mm³) 44.75±15.92 40.46±14.77 0.07 
Ejection fraction (%) 62.83±6.21 63.85±6.59 0.32 
Pulmonary artery pressure (mmHg) 28.89±4.68 30.60±8.44 0.07 
E wave (cm/s) 56.93±13.43 62.02±16.55 0.03 
A wave (cm/s) 70.01±12.22 76.61±14.41 <0.01 
E/A ratio 0.83±0.22 0.82±0.23 0.86 
Deceleration time (ms) 180.74±46.83 178.82±44.86 0.85 
Isovolumetric relaxation time (ms) 83.15±14.77 83.45±17.32 0.90 
Abnormal relaxation (n, %) 36 (90.00) 121 (85.82) 0.06
Septal e´ wave (cm/s) 6.41±1.48 6.33±1.54 0.76 
Septal a´ wave (cm/s) 9.63±1.69 9.85±1.68 0.42 
Septal s´ wave (cm/s) 7.97±1.86 7.87±1.76 0.74 
Septal e/e´ ratio 9.23±2.61 10.25±3.52 0.03
lateral e´ wave (cm/s) 9.36±2.50 8.89±2.43 0.24 
Lateral a´ wave (cm/s) 10.45±2.66 11.48±8.53 0.21 
Lateral s´ wave (cm/s) 9.09±1.86 9.16±2.45 0.82 
Lateral e/e´ ratio 6.64±2.27 7.44±2.52 0.04 
Mean e/e´ ratio 7.97±2.29 8.84±2.74 0.03 
LVEDP: left ventricular end-diastolic pressure, LA: left atrium, LV: left ventricle, ms: millisecond
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To examine possible confounding-adjusted correlations between 
echocardiographic measurements and the LVEDP response to ALR, 
we entered age, sex, and other clinically important variables in a 
multivariate logistic regression analysis as independent variables. 
We controlled for collinearity by checking whether the standard 
error increased greatly or whether the adjusted R2 decreased when 
the new variables were included. P values less than 0.05 were 
considered statistically significant. All analyses were performed 
using the Statistical Package for Social Sciences (SPSS), version 
18.0 (SPSS Inc., Chicago, IL, USA).
Results
Clinical and echocardiographic characteristics
Clinical and echocardiographic parameters are shown in 
Supplementary Table in the online-only Data Supplement. Of 
the total 181 patients, 87 (48.06%) were male, 88 (48.61%) 
had hypertension, and 36 (19.89%) had DM. The mean age was 
58.02±12.84 years (median: 55) and mean body mass index was 
25.09±5.67 kg/m2. Fifty-six (30.94%) patients reported NYHA 
II dyspnea, 112 (61.88%) had NYHA III dyspnea, and 13 (7.18%) 
presented with chest discomfort on exertion. Both exertional 
dyspnea and chest discomfort were present in 23 patients (12.71%). 
Sixty (33.15%) patients complained of edema, and 126 patients 
(69.61%) were being treated with various types of diuretics. 
Cardiomegaly was observed on chest X-ray in 115 patients (63.53%). 
The mean serum BNP level was 48.42±80.42 pg/mL, mean estimated 
glomerular filtration rate was 96.54±19.01 mL/minute, and mean 
total cholesterol was 171.79±41.30 mg/dL. Mean systolic BP was 
135.66±24.33 mmHg, mean diastolic BP was 74.67±17.78 mmHg, 
and mean HR was 74.21±12.75 beats/minute. The mean E/A ratio 
was 0.83±0.32, and the mean septal e/e´ ratio was 10.03±2.53.
Time course of invasively measured left ventricular end-
diastolic pressure and septal e/e´ ratio during leg-raise
As shown in Fig. 2 and Supplement Fig. 1 in the online-only 
Data Supplement, leg-raise exercise significantly increased all 
three LVEDP parameters (minimum, maximum, and frequent), as 
compared with those during the initial resting state (p<0.05). When 
LVEDP was elevated by ALR, most patients complained of dyspnea 
or chest discomfort, which usually developed on daily exercise and 
Table 6. Univariate analysis to predict the LVEDP response to active leg-raise exercise
Parameter β±SE p
95.0% CI of β 
Adjusted R²
Lower Upper Partial correlation
Age (years) 0.12±0.03 <0.00 0.06 0.18 0.27 0.15
Sex -1.65±0.73 0.03 -3.09 -0.21 -0.16 0.05
LV dP/dt (mmHg/s) 1.07x10-4±0.00 0.03 -3.49x10-3 1.29x10-4 -0.16 0.03
E wave (cm/s) 0.04±0.02 0.10 -0.01 0.08 0.12 0.01
A wave (cm/s) 0.1±0.03 <0.01 0.05 0.15 0.26 0.06
Septal e´ wave (cm/s) -0.63±0.24 0.01 -1.10 -0.16 -0.18 0.03
Septal a´ wave (cm/s) 0.04±0.22 0.85 -0.39 0.47 0.01 0.01
Septal e/e´ ratio 0.39±0.11 <0.01 0.18 0.61 0.25 0.06
Lateral e/e´ ratio 0.43±0.15 0.01 0.13 0.73 0.20 0.04
Mean e/e´ ratio 0.48±0.14 <0.01 0.21 0.76 0.24 0.06
LVEDP: left ventricular end-diastolic pressure, SE: standard error, CI: confidence interval, LV: left ventricle
Table 7. Multiple linear regression analysis to predict the LVEDP response to active leg-raise exercise in two models
Model Parameter β±SE p
95.0% CI of β 
Adjusted R²
Collinearity
Lower Upper Partial correlation VIF
Model 1 Age (years) 0.12±0.03 <0.01 0.06 0.18 0.28 0.08 1.00 
Model 2 Age (years) 0.10±0.03 <0.01 0.04 0.16 0.23 1.06 
Septal e/e´ ratio 0.31±0.11 0.01 0.09 0.53 0.19 0.12 1.06 
Age and septal e/e´ ratio are significant predictors of the pattern of LVEDP response during active leg-raise. LVEDP: left ventricular end-diastolic pressure, 
SE: standard error, CI: confidence interval, VIF: variance inflation factor
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activity. During recovery, LVEDP returned almost to baseline levels 
within 3 minutes in the order of minimum, frequent, and maximum. 
Unlike the invasively measured LVEDP, the septal e/e´ ratio during 
PLR and ALR showed no significant changes (Fig. 2). 
Leg-raise exercise also affected the LV hemodynamic parameters. 
Various types of LVSBP, LVDBP, and pre-aLVDP were significantly 
increased. Also, HR and dP/dt values were elevated at the end of ALR 
(p<0.05) (Table 2); in particular, as compared with values obtained 
during the initial resting state, ALR caused significant changes in 
these LV hemodynamic parameters, whereas no significant changes 
were observed during PLR.
Serial changes in invasively measured left ventricular  
end-diastolic pressure during leg-raise exercise
Although leg-raise exercise, especially ALR, caused significant 
increases in all three types of LVEDP in the total study cohort, a 
decrease in the value of LVEDP frequent was observed in 40 patients 
(22.1%) at the end of ALR, as compared with this value at the start 
of ALR. The severity of symptoms correlated with the level and the 
extent of change in LVEDP (∆LVEDP). Patients with decreased LVEDP 
complained of symptoms that were more severe during early exercise, 
when the LVEDP was usually elevated, whereas in patients with 
increased LVEDP, the intensity of the symptoms was proportional 
to the duration of exercise, and symptoms that were more severe 
occurred during late exercise. Based on the ∆LVEDP associated 
with symptoms, the total population was divided into two groups: 
patients were assigned to the ∆LVEDP≤0 mmHg group if LVEDP at 
the end of ALR was lower than that at the start of ALR; the remaining 
patients were assigned to the ∆LVEDP>0 mmHg group.
As shown in Fig. 3, the mean value of LVEDP frequent at the end 
of ALR was 24.90±2.50 mmHg in the total population, 27.90±2.92 
mmHg in the ∆LVEDP>0 mmHg group, and 14.30±2.18 mmHg in the 
∆LVEDP≤0 mmHg group (p<0.01). Although the difference was not 
significant, LVEDP levels in the ∆LVEDP≤0 mmHg group remained 
lower throughout PLR than did those in the ∆LVEDP>0 mmHg group. 
Irrespective of the initial LVEDP level or response to ALR, however, all 
types of LVEDP were more significantly increased at the end of PLR 
when compared with the initial LVEDP (p<0.05) (Fig. 3).
In contrast to PLR, the LVEDP responses to ALR were clearly 
discriminated between the two groups. The LVEDP in the ∆LVEDP>0 
mmHg group was increased steadily and significantly during the 
first 60 seconds of ALR and remained constantly elevated until the 
end of ALR. The LVEDP in the ∆LVEDP≤0 mmHg group was slightly 
elevated during early ALR. But declined significantly declined after 
90 seconds of ALR and progressively decreased until the end of 
ALR. The patterns of recovery also differed considerably. The LVEDP 
in the ∆LVEDP≤0 mmHg group returned to the initial value of 
ALR within 60 seconds after ALR was terminated, whereas in the 
∆LVEDP>0 mmHg group the rate of recovery of LVEDP was slower 
and was restored to normal values within 180 seconds after ALR 
was over (Fig. 3).
Septal e/e´ ratios in the ∆LVEDP≤0 mmHg group were significantly 
lower at the start (initial rest), on PLR, and on ALR, as compared 
with those in the ∆LVEDP>0 mmHg group. However, septal e/e´ 
ratios were not significantly changed throughout PLR and ALR. 
During recovery, the e/e´ ratios were restored to their initial levels 
within 3 minutes, and the differences were sustained constantly 
and significantly between the two groups (Fig. 4).
Comparison of clinical characteristics according to the pattern 
of left ventricular end-diastolic pressure response to leg-raise
During PLR, LVEDP in the ∆LVEDP≤0 mmHg group was elevated 
by a mean of 1.00±2.28 mmHg and increased by 1.50±2.36 
mmHg in the ∆LVEDP>0 mmHg group. During ALR, LVEDP in the 
∆LVEDP≤0 mmHg group decreased by a mean of -4.10±3.21 mmHg 
and increased by a mean of 7.89±5.24 mmHg in the ∆LVEDP>0 
mmHg group (p<0.001) (Table 3). Thus, LVEDP in the ∆LVEDP≤0 
mmHg group decreased by a mean of -2.90±4.07 mmHg, whereas 
LVEDP in the ∆LVEDP>0 mmHg group was elevated by a mean 
of 9.68±5.75 mmHg (p<0.001) (Table 3). Although the extent of 
change during ALR was similar in the two groups, the dP/dt value in 
the ∆LVEDP≤0 mmHg group was higher during the initial stage and 
at the end of ALR (p<0.05) (Table 3 and Supplement Fig. 2 in the 
online-only Data Supplement). The ∆LVEDP≤0 mmHg group had a 
higher HR during the initial stage and during leg-raise, although 
the difference was not significant (Table 3 and Supplement Fig. 3 
in the online-only Data Supplement). At the initial stage, the LVEDP 
variables showed no difference between the two groups, whereas 
the values for all the types of LVEDP variables during ALR were 
significantly lower in the ∆LVEDP≤0 mmHg group (p<0.001) (Table 
3). Pre-aLVDP parameters showed no difference between the two 
groups during the initial stage but were lower at the end of ALR 
in the ∆LVEDP≤0 mmHg group (p<0.001) (Table 3). Various types 
of LVDBP and LVSBP parameters showed no significant differences 
between the two groups (Table 3).
The most significant difference was that the mean age of the 
∆LVEDP≤0 mmHg group was lower than that of the ∆LVEDP>0 
mmHg group (p<0.01) (Table 4). Except for age, no other clinical 
and laboratory parameters differed significantly between the two 
groups (Table 4). Among the TTE parameters, the E and A waves 
were lower in the ∆LVEDP≤0 mmHg group, but the E/A ratio was 
similar in the two groups. Unlike the E/A ratio, the septal e/e´ ratio, 
lateral e/e´ ratio, and mean e/e´ ratio were all significantly lower in 
the ∆LVEDP≤0 mmHg group (p<0.05) (Table 5).
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Model for predicting the pattern of left ventricular  
end-diastolic pressure response during active leg-raise
On univariate analysis, we found that age, sex, dP/dt, A wave, 
septal e´ wave, septal e/e´ ratio, lateral e/e´ ratio, and mean e/e´ ratio 
were all significantly associated with the pattern of LVEDP response 
during ALR (p<0.05) (Table 6). On multivariate analysis to predict 
the changes in LVEDP during ALR, both age and septal e/e´ ratio 
remained significant predictors (p<0.01) (Table 7).
Discussion
This study demonstrated the serial changes of LV hemodynamics 
during leg-raise exercise in patients with early HFpEF who 
underwent left cardiac catheterization. This helps us to understand 
how LV hemodynamics respond to exercise in euvolemic patients 
with exertional dyspnea or dyspnea-equivalent symptoms. The 
increase in LVEDP seen only during exercise in the patients with 
exertional dyspnea and normal BNP is in agreement with the 
results of previous studies.2-5)8) First of all, the stress test for 
diastolic functional assessment has hitherto not been feasible in 
patients undergoing CAG or cardiac catheterization. Our study 
showed that the measurement of LVEDP during leg-raise exercise 
may be considered as a simple option to assess diastolic function 
or to document whether exertional symptoms are associated with 
early HFpEF in patients with nonsignificant coronary stenosis.
The most novel finding in this study is the two distinct patterns 
of LVEDP changes observed during ALR in patients with early 
HFpEF. Elevated LV filling pressure and impaired DFR have been 
identified in HFpEF during exercise.1)2)8) As expected, LVEDP 
increased steadily in most of the patients (77.9%) throughout ALR. 
In contrast, LVEDP increased moderately during the early stage 
of ALR and then declined during the late stage in 22.1% patients. 
Biphasic changes in LVEDP seen during exercise were previously 
reported in nonobstructive hypertrophic cardiomyopathy (HCM).16) 
Severe HCM had caused a steady increase in LVEDP throughout 
exercise, whereas mild to moderate HCM led to biphasic changes 
in LVEDP.16) In a similar context, the severity of LV hypertrophy 
(LVH) was reported to determine the hemodynamic responses to 
exercise and also to be inversely associated with LV functional 
reserve during exercise.16)17) However, patients with HCM were 
excluded from our study population. In addition, in our study, LVH 
or an LV mass caused no difference between the ∆LVEDP≤0 mmHg 
and ∆LVEDP>0 mmHg groups, which suggests that the LVEDP 
response to ALR was not determined by the severity of LVH. On 
the contrary, our study showed that the LVEDP response to ALR 
was significantly associated with the e/e´ ratios rather than with 
LVH or an LV mass. This finding highlights the fact that the change 
in LVEDP in response to ALR depends mainly on LV hemodynamics 
rather than on LV geometry.
Biphasic changes of LVEDP in HCM were related to improved 
coronary microcirculation in response to beta-adrenergic stimulation 
and metabolic vasodilation induced by beta-adrenergic activation.16) 
Likewise, in our study, the two distinct responses of LVEDP to the 
ALR test might be ascribed to the individual person’s diastolic 
capacity and to different responses to beta-adrenergic stimulation. 
The finding that patients with ∆LVEDP≤0 mmHg were younger 
and had a lower e/e´ ratio at rest contains the key to solving this 
puzzle. Although age may be an unmeasured confounder, most 
abnormalities seen in patients with HFpEF are also noted with normal 
aging. As the enhancements in HR, contractility, and peripheral 
vasodilation become impaired with aging, HFpEF is inevitably 
more dependent on diastolic reserve during exercise.8) Enhanced 
diastolic LV filling is normally achieved through contraction to 
lower end-systolic volumes and enhance relaxation. However, 
increased LV chamber stiffness and inadequate enhancement 
of relaxation are the key mechanisms in HFpEF.4) In the absence 
of volume overload, LVEDP is determined by LV relaxation and 
myocardial stiffness, which is regulated by the extracellular matrix 
(collagen deposition) and intrinsic cardiomyocyte stiffness.7) Thus, 
essential components in decreasing LVEDP are the improvement 
in LV relaxation and reduction in myocardial stiffness. Normally, 
isovolumic relaxation rates increase with supine exercise, and the 
LV can fill to greater preload volumes during a shorter interval.8) 
This highlights that enhanced diastolic LV filling is not achieved 
only by leg-raise, age, or e/e´ ratio. Conversely, despite impaired 
LV relaxation or myocardial stiffness, it inherently has a potential 
to compensate for the increased LVEDP during early ALR. In other 
words, the patients with a decreased LVEDP response might have 
a relatively compliant LV with preserved relaxation but will never 
have normal LV function — the so-called earlier stage of HFpEF — 
whereas those with increased LVEDP are likely to have a stiffer LV 
with more impaired relaxation and decreased compliance.
Another interesting finding was that, although LVEDP in the 
∆LVEDP≤0 mmHg group was elevated by a mean of 1.0±2.28 mmHg 
at the end of PLR (∆LVEDP>0 mmHg group; 1.50±2.36 mmHg), the 
extent of increase in LVEDP during PLR — suggesting the effect of 
preload on LVEDP — was not associated with the extent of decrease 
in LVEDP during ALR. Thus, a decreased LVEDP in response to ALR 
must be attributed to preload-independent factors. In previous 
studies, sympathetic tone determined the DFR during exercise.1) In 
our study, ALR significantly increased HR and LVSBP, whereas no 
significant changes were observed in HR and BP during PLR. This 
finding indicates that sympathetic activity may be the main effector 
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of the LVEDP response to ALR. Similarly, biphasic LVEDP changes 
in HCM disappeared after the administration of propranolol.16) 
During exercise, diastolic LV filling is augmented through increased 
elastic recoil and enhanced LV relaxation related to beta-adrenergic 
stimulation (which promote augmented diastolic “suction”).8)18) 
However, because enhancement of a diastolic relaxation response 
to exercise-induced adrenergic stimulation was blunted in the 
patients with HFpEF, the insufficient ventriculoatrial suction 
occurred during early diastole and eventually led to an increase 
in LVEDP.8)18) Taken together, a decreased LVEDP in response to 
ALR may be due to the less blunted enhancement of the diastolic 
relaxation response to exercise-induced adrenergic stimulation, 
which also indicates an earlier stage of HFpEF.
Just as HFpEF is reflected in a wide spectrum of diastolic 
abnormalities, so may there be various stages in the response to 
therapy in patients with early HFpEF. Interestingly, the severity of 
dyspnea correlated with the LVEDP level and extent of its change 
(∆LVEDP). Patients with ∆LVEDP≤0 mmHg complained of more 
severe dyspnea during early exercise. The LVEDP in those patients 
declined after the early stage of exercise, which coincided with the 
change in the intensity of symptoms. This underlines the notion 
that maintaining steady and regular exercise at a constant strength 
level may decrease LVEDP and thus have a role in the treatment of 
HFpEF. In reality, there is no proven pharmacotherapy to improve 
survival in patients with HFpEF, and exercise training is the best 
option for improving LV diastolic function, exercise capacity, and 
quality of life.3)19)20) In contrast, based on our result that the leg-
raise exercise accelerated an increase in LVEDP in patients with 
∆LVEDP>0 mmHg, the benefit of exercise may at most be smaller in 
this group. That is, early HFpEF may be at a reversible stage where 
exercise decreases LVEDP and therapy induces a good response.
Another novel finding of our study is that the serial changes 
of the invasively measured LVEDP to the leg-raise exercise were 
inconsistent with the changes in the septal e/e´ ratio. This mismatch 
was previously reported in the RALI-DHF (RAnoLazIne for the 
Treatment of Diastolic Heart Failure) study.20) Until now, the e/e´ ratio 
has been thought to reflect LV filling pressure, and serial changes 
in the e/e´ ratio have been recognized as evidence in determining 
the diagnosis in patients with diastolic dysfunction.2)7) In this 
study, sequential LVEDP responses to the leg-raise test changed 
significantly in patients with early HFpEF, whereas no significant 
changes were observed in the e/e´ ratio. This underlines the fact 
that the e/e´ ratio does not reflect an immediate change in LVEDP; 
however, it does not mean that the e/e´ ratio is not associated with 
LVEDP. First of all, the patients who showed serial changes in the 
e/e´ ratio on the DSE had undergone overt decompensation and 
hospitalization, whereas our study group consisted of patients 
with early HFpEF who had never been admitted to the hospital 
with overt HF. Second, the invasively measured LVEDP and serial 
e/e´ ratio measurements during leg-raising were not obtained 
simultaneously, and this time lag might have caused a mismatch 
between data.
Finally, our study should be interpreted within the context of its 
limitations. First of all, in addition to the patients who had effort 
dyspnea, those with chest discomfort on exertion were initially 
screened and recruited for the study, which might be considered 
a limitation. However, in outpatient practice, exertional chest 
discomfort often cannot be clearly distinguished from exertional 
dyspnea. Even though both symptoms are sometimes combined, 
they may be ignored or missed owing to indifference on the part 
of the examiner or to a preconception taken for granted. Moreover, 
because there is no proven therapy, the benefit of the patient must 
be considered first and foremost when one is considering invasive 
procedures to assess hemodynamic diastolic function or to 
diagnose early HF. In terms of diagnostic, interventional, practical, 
and economic efficacy, the invasive procedure to determine and 
document the causes of symptoms must be the most reasonable 
practice when scheduling patients for CAG if they are found to 
have nonsignificant coronary artery stenosis. In other words, 
because the heterogeneous population was a natural result and 
reflects actual practice to the utmost, it may be considered an 
advantage and benefit rather than a limitation. In fact, the leg-
raise exercise is directly and easily applicable to real practice and 
obviates the expense of additional time, place, or device. Thus, the 
focus of our study was not to adhere strictly to the condition of 
whether chest discomfort on exertion is a diagnostic criterion of 
HFpEF, but rather to detect elevated LVEDP in patients with chest 
discomfort on exertion, corresponding to early HFpEF.
Second, we enrolled only those patients with a BNP level below 
200 pg/mL. These low levels may be controversial, although 
BNP<200 pg/mL was actually an inclusion criterion for invasive 
hemodynamic stress testing in a previous study.2) As BNP>200 pg/
mL is the recommended ESC cutoff for the diagnosis of HFpEF,6) 
patients who present with symptoms of HF and a BNP>200 pg/mL 
can be clinically diagnosed as having HF, and thus invasive stress 
testing may add negligible additional benefits. Moreover, previous 
studies have shown that BNP has a limited role in early HFpEF.2)5)21) 
Despite severe subjective and objective exercise intolerance in 
patients with clinically diagnosed HFpEF, average N-terminal 
proBNP levels were found to be similar to those in healthy 
controls.21) The noninvasive markers of congestion fall within the 
normal range if filling pressures are only intermittently elevated, 
such as during exercise.2)
Third, because our results were analyzed as a cross-sectional 
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study, the effect of leg-raise exercise on LV hemodynamics or DFR 
was not sufficient to establish a cause–effect relation or underlying 
mechanisms. In addition, we could not demonstrate how the 
LVEDP response to ALR was associated with clinical outcomes. Our 
findings should be recognized as hypothesis-generating and as 
requiring further confirmative studies.
In conclusion, on the basis of LVEDP change (∆LVEDP) as a marker 
of DFR, biphasic changes in LVEDP in response to the ALR test is a 
useful criterion of functional reserve to stratify patients with early 
HFpEF. Despite a similar LVEDP at rest, the various spectra of LV 
hemodynamic responses to exercise and clinical manifestations 
may be observed in early HFpEF, depending on the individual’s 
diastolic capacity. With the exception of age and septal e/e´ ratio, 
various types of parameters at rest did not predict the LVEDP 
response to ALR. Thus, in early HFpEF that does not meet currently 
used diagnostic criteria, invasive exercise stress testing plays an 
important role in both the diagnosis of HFpEF and the elucidation 
of an individual’s capacity of diastolic property. Moreover, because 
not all patients with HFpEF satisfy the criteria specified in the 
current guidelines, one should avoid diagnosing HFpEF on the basis 
of BNP alone or a noninvasive marker of filling pressure at rest, 
especially in terms of early HFpEF.2)
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